Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    0.00 (0.00%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Acquisition

5 Dec 2016 07:00

RNS Number : 8831Q
Helios Underwriting Plc
05 December 2016
 

5 December 2016

 

Helios Underwriting plc

("Helios" or the "Company")

 

Acquisition of Salviscount LLP

 

 

Acquisition of Salviscount LLP

 

Helios is pleased to announce that, in line with its strategy of increasing underwriting capacity through acquisition, on 2 December 2016 it acquired Salviscoint Limited Liability Partnership (Salviscount), a limited liability member of Lloyd's ("LLV"), for a consideration of £0.8 million in cash. The 2016 underwriting capacity of Salviscount is £1.0 million (this compares with Helios's 2016 capacity of £32.7 million prior to this acquisition). Salviscount participates in a spread of Lloyd's syndicates broadly similar to Helios's own participation. The capacity acquired, which Helios expects to retain, is as follows:

 

 Salviscount LLP

 

Year of Account

 

 

2014

2015

2016

 

£m

£m

£m

Retained

1.08

0.9

1.0

Reinsured

-

-

-

Total Capacity

1.08

0.9

1.0

 

 

Commenting upon the acquisition, Nigel Hanbury, the Company's Chief Executive Officer, said:

"We are delighted to have made a further acquisition which further increases our underwriting capacity. This is in line with our stated strategy of acquiring corporate members as suitable opportunities arise. We continue to believe that there remain significant opportunities for further growth available to the Company."

 

Additional information

Salviscount LLP (Salviscount) is a limited liability member of Lloyd's. In the year ended 31 December 2015, Salviscount made a profit before tax of £0.118m on gross premiums written of £0.881m and its net asset value at completion is expected to be approximately £0.8m, including underwriting capacity with an estimated market value of £0.4m.

 

 

Set out below are Salviscount's 2014 and 2015 open years of account forecasts:

 

YOA

Salviscount

syndicate capacity

(£'000)

Forecast of syndicate profit

(30 September 2016)

Mid point

(£'000)

Mid point

(%)

Range

(%)

2014

1,084

123

11.37

14.77% - 7.97%

2015

936

67

7.2%

11.19% - 3.20%

 

Source: Syndicate data and Helios analysis (before early release)

 

 

 

For further information please contact:

 

Helios

Nigel Hanbury - Chief Executive

Arthur Manners

 

020 7863 6655 / nigel.hanbury@huwplc.com

07754 965 917

 

 

Stockdale

Robert Finlay

 

 

020 7601 6100

 

 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £32 million of capacity for the 2016 account. The portfolio provides a good spread of classes of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTTBRTMBJMBIF
Date   Source Headline
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change
29th May 20257:03 amRNSCompany Announcement
29th May 20257:00 amRNSHelios Underwriting 2024 Preliminary Results
20th May 20257:00 amRNSNotice of Results and Change in Accounting
10th Apr 20253:41 pmRNSDirector Shareholding
9th Apr 202512:22 pmRNSDirector/PDMR Shareholding
8th Apr 20257:02 amRNSShare Repurchase Programme - 2025
8th Apr 20257:00 amRNSNet Asset Value as at 31 December 2024
13th Mar 20257:00 amRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSDirectorate Change
18th Dec 20247:00 amRNS2025 Capacity Update
15th Nov 20247:00 amRNSCapacity Value Update
3rd Oct 20242:08 pmRNSInvestor Presentation via Investor Meet Company
30th Sep 20247:00 amRNSGrant of LTIP Awards
27th Sep 20247:00 amRNSHalf Year Results
23rd Sep 20247:00 amRNSTR-1: Notification of major holdings
30th Aug 20247:00 amRNSAppointment of Non-Executive Director
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20247:00 amRNSNet Asset Value as at 31 March 2024
24th Jul 20245:36 pmRNSHolding(s) in Company
23rd Jul 20245:05 pmRNSCompletion of Share Buy-Back
17th Jul 20248:50 amRNSDirector/PDMR Shareholding
12th Jul 20247:00 amRNSIssue of Equity
10th Jul 20247:00 amRNSResults of Scrip Dividend Election
9th Jul 20247:00 amRNSShare Repurchase Programme - 2024
1st Jul 20247:00 amRNSDirectorate Change
28th Jun 202411:25 amRNSResults of Annual General Meeting
28th Jun 20247:00 amRNSAGM Statement
19th Jun 20247:00 amRNSShare Repurchase Programme
17th Jun 20247:00 amRNSGrant of LTIP Awards
14th Jun 20247:00 amRNSScrip Dividend Reference Price
7th Jun 20247:00 amRNSDirectorate Change
4th Jun 20247:00 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20243:19 pmRNSDirector's Shareholding
30th May 20247:00 amRNSFinal results for the year ended 31 December 2023
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.